Guides / Mounjaro (tirzepatide)
How to Appeal a Mounjaro (Tirzepatide) Denial
Denied Mounjaro? It is FDA-approved for type 2 diabetes. The strongest appeals tie it to glycemic control and document why the plan’s preferred alternatives are inappropriate for you.
Your deadline: most plans allow 180 days from the date on your denial letter to file an internal appeal — more time than most people think. Check the date on your letter.
Why Mounjaro (tirzepatide) claims get denied
- Step therapy — try metformin or another agent first
- Prior authorization criteria not documented
- Denied as "for weight loss" — Mounjaro is approved for diabetes; Zepbound is the obesity version
- Quantity limits
The argument that wins
- If you have type 2 diabetes, build a medical-necessity case for glycemic control with your A1c history and why preferred agents failed or are inappropriate.
- Request a step-therapy exception based on intolerance, contraindication, or prior failure of the required drugs.
- Honest note: for weight management without diabetes, the on-label tirzepatide product is Zepbound — an appeal for that indication is usually stronger directed at Zepbound.
Evidence to gather
- Your type 2 diabetes diagnosis and recent A1c results
- Records of prior diabetes medications tried and their outcomes
- A letter of medical necessity from your prescriber
Related appeal guides
- Appeal a Zepbound (tirzepatide) denial
- Appeal a Wegovy (semaglutide) denial
- Appeal a Ozempic (semaglutide) denial
- Weight-loss medication (GLP-1) appeals — overview
Want this done for you?
Run a free case check — we read your denial, tell you if it’s appealable, and only charge ($149 flat) if it is. Expert-reviewed appeal in 2 business days.
Check my denial — freeFrequently asked questions
Can I appeal a Mounjaro denial if I have diabetes?
Yes. Mounjaro is FDA-approved for type 2 diabetes. Document your A1c, the diabetes diagnosis, and why preferred alternatives are inappropriate, and request a step-therapy exception if needed.
Mounjaro vs Zepbound — does it matter for my appeal?
They are the same molecule (tirzepatide) from the same maker, but Mounjaro is FDA-approved for diabetes and Zepbound for weight management and sleep apnea. Appeal the product that matches your indication.